These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16037824)

  • 1. Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.
    Stiles BM; Adusumilli PS; Bhargava A; Stanziale SF; Kim TH; Chan MK; Huq R; Wong R; Rusch VW; Fong Y
    Cancer Gene Ther; 2006 Jan; 13(1):53-64. PubMed ID: 16037824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer.
    Stanziale SF; Stiles BM; Bhargava A; Kerns SA; Kalakonda N; Fong Y
    Hum Gene Ther; 2004 Jun; 15(6):609-18. PubMed ID: 15212719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer.
    Stiles BM; Bhargava A; Adusumilli PS; Stanziale SF; Kim TH; Rusch VW; Fong Y
    Surgery; 2003 Aug; 134(2):357-64. PubMed ID: 12947341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses.
    Adusumilli PS; Stiles BM; Chan MK; Mullerad M; Eisenberg DP; Ben-Porat L; Huq R; Rusch VW; Fong Y
    J Gene Med; 2006 May; 8(5):603-15. PubMed ID: 16475242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus.
    Adusumilli PS; Eisenberg DP; Stiles BM; Chung S; Chan MK; Rusch VW; Fong Y
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1179-88. PubMed ID: 17059941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with oncolytic herpes simplex virus-1 induces apoptosis in neighboring human cancer cells: a potential target to increase anticancer activity.
    Stanziale SF; Petrowsky H; Adusumilli PS; Ben-Porat L; Gonen M; Fong Y
    Clin Cancer Res; 2004 May; 10(9):3225-32. PubMed ID: 15131064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally invasive oncological surgery.
    Adusumilli PS; Stiles BM; Chan MK; Eisenberg DP; Yu Z; Stanziale SF; Huq R; Wong RJ; Rusch VW; Fong Y
    FASEB J; 2006 Apr; 20(6):726-8. PubMed ID: 16467372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma.
    Adusumilli PS; Chan MK; Chun YS; Hezel M; Chou TC; Rusch VW; Fong Y
    Cancer Biol Ther; 2006 Jan; 5(1):48-53. PubMed ID: 16294031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging.
    Adusumilli PS; Eisenberg DP; Stiles BM; Hendershott KJ; Stanziale SF; Chan MK; Hezel M; Huq R; Rusch VW; Fong Y
    Surg Endosc; 2006 Apr; 20(4):628-35. PubMed ID: 16446989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro detection of cholangiocarcinoma cells using a fluorescent protein-expressing oncolytic herpes virus.
    Coelen RJS; de Keijzer MJ; Weijer R; Loukachov VV; Wiggers JK; Mul FPJ; van Wijk ACWA; Fong Y; Heger M; van Gulik TM
    Cancer Gene Ther; 2017 May; 24(5):227-232. PubMed ID: 28409558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer.
    Adusumilli PS; Stiles BM; Chan MK; Chou TC; Wong RJ; Rusch VW; Fong Y
    Ann Thorac Surg; 2005 Aug; 80(2):409-16; discussion 416-7. PubMed ID: 16039175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery.
    Adusumilli PS; Eisenberg DP; Chun YS; Ryu KW; Ben-Porat L; Hendershott KJ; Chan MK; Huq R; Riedl CC; Fong Y
    J Gastrointest Surg; 2005 Nov; 9(8):1138-46; discussion 1146-7. PubMed ID: 16269385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
    Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma.
    Mullerad M; Bochner BH; Adusumilli PS; Bhargava A; Kikuchi E; Hui-Ni C; Kattan MW; Chou TC; Fong Y
    J Urol; 2005 Aug; 174(2):741-6. PubMed ID: 16006968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors.
    Yamamoto S; Deckter LA; Kasai K; Chiocca EA; Saeki Y
    Gene Ther; 2006 Dec; 13(24):1731-6. PubMed ID: 16871231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time fluorescence imaging of abdominal, pleural, and lymphatic metastases.
    Carpenter S; Fong Y
    Methods Mol Biol; 2012; 872():141-57. PubMed ID: 22700409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time intraoperative detection of breast cancer axillary lymph node metastases using a green fluorescent protein-expressing herpes virus.
    Eisenberg DP; Adusumilli PS; Hendershott KJ; Chung S; Yu Z; Chan MK; Hezel M; Wong RJ; Fong Y
    Ann Surg; 2006 Jun; 243(6):824-30; discussion 830-2. PubMed ID: 16772786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the enhanced green fluorescent protein by herpes simplex virus type 1 (HSV-1) as an in vitro or in vivo marker for virus entry and replication.
    Foster TP; Rybachuk GV; Kousoulas KG
    J Virol Methods; 1998 Nov; 75(2):151-60. PubMed ID: 9870590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence-assisted cytological testing (FACT): Ex Vivo viral method for enhancing detection of rare cancer cells in body fluids.
    Adusumilli PS; Gholami S; Chun YS; Mullerad M; Chan MK; Yu Z; Ben-Porat L; Rusch VW; Fong Y
    Mol Med; 2011; 17(7-8):628-34. PubMed ID: 21487639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.